Industry reports 76 deals worth $5B in June 2023: GlobalData
The pharma industry reported 88 VC deals worth $2.5B in June 2024, compared to the last 12-month (June 2023 to May 2024) average…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pharma market
71 per cent rise YoY during Q1 2024 in Biopharmaceutical M&A deals: GlobalData
GlobalData’s recent The State of the Biopharmaceutical Industry 2024 report reveals that the surveyed healthcare industry…
Credit profile of Indian pharma cos to remain healthy in FY2025 despite moderation in revenue…
Revenue growth to moderate to 8-10 per cent in FY2025, post a healthy 13-14 per cent YoY expansion in FY2024
Novel therapies to drive Crohn’s disease market growth across 8MM to $15 bn by 2032: GlobalData
An anticipated 11 assets in the late-stage pipeline will enter the CD market during the forecast period
LIC sells over two per cent stake in Sun Pharma for Rs 4,699 cr
Corporation's shareholding in Sun Pharma has decreased from 5.023 per cent to 3.012 per cent of the paid-up capital of the said…
Balaxi Pharma reports 23 per cent growth YoY during Q2FY23
Pharma revenue up 50 per cent with expanding contribution from Latin America
Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables
The drug major also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further…
Domestic pharma industry revenues projected to grow six to eight per cent in FY23: ICRA
Growth in FY2023 is expected to be supported by growth of seven-to-nine per cent in the domestic market, 12-14 per cent in the…
Pharma deals value decreases by 74.5 per cent in March 2022
The industry reported 163 Venture Capital (VC) deals worth $3.1 billion in March 2022, compared to the last 12-month average…
CPhI Worldwide releases pharma market predictions for 2022
The findings suggest a robust and prosperous year ahead for the contract services industry